| __timestamp | Bristol-Myers Squibb Company | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 5699000000 | 38783000000 |
| Thursday, January 1, 2015 | 5001000000 | 42585000000 |
| Friday, January 1, 2016 | 5002000000 | 45702000000 |
| Sunday, January 1, 2017 | 4849000000 | 46372000000 |
| Monday, January 1, 2018 | 4551000000 | 46910000000 |
| Tuesday, January 1, 2019 | 4871000000 | 48890000000 |
| Wednesday, January 1, 2020 | 7661000000 | 50129000000 |
| Friday, January 1, 2021 | 7690000000 | 54559000000 |
| Saturday, January 1, 2022 | 7814000000 | 62081000000 |
| Sunday, January 1, 2023 | 7772000000 | 105931000000 |
| Monday, January 1, 2024 | 8414000000 | 77201000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited, two industry titans, have shown contrasting approaches over the past decade. From 2014 to 2023, Bristol-Myers Squibb's SG&A expenses fluctuated, peaking in 2022 with a 72% increase from 2018. In contrast, Dr. Reddy's Laboratories consistently increased their SG&A spending, culminating in a staggering 173% rise by 2023 compared to 2014. This divergence highlights differing strategic priorities: while Bristol-Myers Squibb may focus on cost containment, Dr. Reddy's appears to invest heavily in growth and expansion. The data for 2024 is incomplete, leaving room for speculation on future trends. As these companies navigate the ever-evolving pharmaceutical landscape, their SG&A strategies will undoubtedly play a pivotal role in their financial health.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company or Zoetis Inc.: Who Manages SG&A Costs Better?
Bristol-Myers Squibb Company or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Neurocrine Biosciences, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Zoetis Inc. vs Dr. Reddy's Laboratories Limited: SG&A Expense Trends
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.